These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20934121)

  • 1. A study on pollen allergens in China.
    Liu ZG; Song JJ; Kong XL
    Biomed Environ Sci; 2010 Aug; 23(4):319-22. PubMed ID: 20934121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in allergen-specific IgG-4 during desensitization of patients with hay fever and those sensitized to housedust allergens].
    Kruszewski J
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():31-9. PubMed ID: 1843806
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hay fever: pollinosis].
    Ado VA; Astaf'eva NG; Goriachkina LA
    Sov Med; 1981; (6):61-6. PubMed ID: 7025247
    [No Abstract]   [Full Text] [Related]  

  • 4. Study on specific immunotherapy with the aid of 3M Diagnostic Systems' tests.
    Stasiak-Barmuta A; Dabrowska I; Piotrowska T; Hofman J
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():53-6. PubMed ID: 1292848
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allergic rhinitis. This year the pollen count is expected to be high].
    Hellmann A
    MMW Fortschr Med; 2006 May; 148(21):51-2. PubMed ID: 16796189
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials with recombinant allergens--three perspectives: industry.
    Narkus A; Kniest F; Menzel A; Meyer H; Sprung V
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():270-5; discussion 275-8. PubMed ID: 20799471
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
    Klimek L; Schendzielorz P; Pinol R; Pfaar O
    Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations among air pollutants, grass pollens, and daily number of grass pollen allergen-positive patients: a longitudinal study from 2012 to 2016.
    Ouyang Y; Yin Z; Li Y; Fan E; Zhang L
    Int Forum Allergy Rhinol; 2019 Nov; 9(11):1297-1303. PubMed ID: 31513736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D
    Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
    Czarnecka-Operacz M; Jenerowicz D; Silny W
    Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of airborne pollen in Hubei province of China.
    Liu GH; Zhu RF; Zhang W; Li WJ; Wang ZX; Chen H
    Chin Med Sci J; 2008 Dec; 23(4):212-7. PubMed ID: 19180881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A survey of main allergic pollen in pollinosis in district of Wuhan].
    Liu G; Huang X; Li H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 May; 12(5):226-7, 230. PubMed ID: 11189163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [News on environmental impact on pollen and allergies].
    Behrendt H
    Krankenpfl J; 2005; 43(7-10):259. PubMed ID: 16515329
    [No Abstract]   [Full Text] [Related]  

  • 15. Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study.
    Pfaar O; Barth C; Jaschke C; Hörmann K; Klimek L
    Int Arch Allergy Immunol; 2011; 154(4):336-44. PubMed ID: 20975285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pollen-Induced Allergic Asthma and Rhinoconjunctivitis: Differences in Outcome Between Seasonal and Nonseasonal Exposure to Allergens Under Real-Life Conditions (The LANDSCAPE Study).
    Dominguez-Ortega J; Navarro A; Delgado Romero J; Dordal T; Habernau A; Rodríguez M; Mur-Gimeno P; González Gutiérrez ML; Pérez-Francés C; Pascual Miravalles MJ; Colás C; Dávila I; Rodríguez Fernández F; Sánchez Hernández MC; Valero A;
    J Investig Allergol Clin Immunol; 2020; 30(6):454-456. PubMed ID: 32376518
    [No Abstract]   [Full Text] [Related]  

  • 17. Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals.
    Riediker M; Monn C; Koller T; Stahel WA; Wüthrich B
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):311-8. PubMed ID: 11686424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis.
    Pfaar O; Robinson DS; Sager A; Emuzyte R
    Allergy; 2010 Dec; 65(12):1614-21. PubMed ID: 20645937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T; Latif L; Petersson-Westin U; Cardell LO
    J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dangerous liaison between pollens and pollution in respiratory allergy.
    Schiavoni G; D'Amato G; Afferni C
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):269-275. PubMed ID: 28143681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.